Home
>
National Drug Code (NDC)
>
CASODEX
CASODEX - 0310-0705-30 - (Bicalutamide)
Drug Information of CASODEX
| Product NDC: | 0310-0705 |
| Proprietary Name: | CASODEX |
| Non Proprietary Name: | Bicalutamide |
| Active Ingredient(s): | 50 mg/1 & nbsp; Bicalutamide |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of CASODEX
| Product NDC: | 0310-0705 |
| Labeler Name: | AstraZeneca Pharmaceuticals LP |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020498 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19951016 |
Package Information of CASODEX
| Package NDC: | 0310-0705-30 |
| Package Description: | 30 TABLET in 1 BOTTLE, PLASTIC (0310-0705-30) |
NDC Information of CASODEX
| NDC Code | 0310-0705-30 |
| Proprietary Name | CASODEX |
| Package Description | 30 TABLET in 1 BOTTLE, PLASTIC (0310-0705-30) |
| Product NDC | 0310-0705 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Bicalutamide |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19951016 |
| Marketing Category Name | NDA |
| Labeler Name | AstraZeneca Pharmaceuticals LP |
| Substance Name | BICALUTAMIDE |
| Strength Number | 50 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Androgen Receptor Antagonists [MoA],Androgen Receptor Inhibitor [EPC] |
